PPT-Stratifying stroke risk to guide antithrombotic therapy in patients with AF

No evidence that AF type significantly impacts stroke risk Scandinavian followup study of patients treated for paroxysmal n855 and permanent AF n1126 during 2002 mean followup 36 years Aim to investigate differences in stroke risk in the two cohorts. Ron Pellegrino, MD. November 20, 2015. Objectives. Become comfortable with risk factor modification and chronic management of the post stroke patient.. Review the major modifiable risk factors. HTN guidelines for long term management of ischemic stroke. Sarah L. Livesay, DNP, RN, ACNP-BC. Assistant Professor. Rush University. Typical V. Atypical: Semantics?. Stroke identification according to the AHA/ASA. ASA . 5 . Suddens. Numbness or weakness of leg, arm, face. thrombotics. in patients undergoing GI endoscopy. Dr Osman . Mapkar. Gastroenterolgy. Unit . Jahra. Hospital. Antithrombotic therapy. Indications. AF. ACS. DVT. Hypercoagulable states. Endoprostheses. Journal Club . October 21,2015. Kathleen McNamara, . PharmD. Stroke Risk Calculation. Which tool do you most typically use to evaluate stroke . risk for patients with a fib? . CHADS2 score. CHADS2-VASc. Assistant Professor. Department of Internal Medicine – Hospital Medicine Division. Medical Director – UNM Anticoagulation Clinic. Co-Director Antithrombotic Stewardship. Roadmap. Direct oral anticoagulants. Lama Al-Khoury, MD. Clinical Assistant Professor. Neurology. UCI Medical Center. Dec 8. th. , 2014. Stroke Epidemiology. Incidence of stroke in . USA. is 795,000/ year in the United States of America. National Stroke Association. ADVOCATE. – Influence public policy and legislation on stroke survivor issues.. EDUCATE. – Spread the word about stroke awareness.. PARTICIPATE. – Get involved and make a difference in the world of stroke.. Approach to TIA and Management of Stroke after 4.5 hours Robert Altman R4 McGill University August 25 th 2010 Summer Emergency Lecture Series What to take out of today. Everything I’m presenting is The Best of Both Worlds in CAD/PAD: The Emerging Role of Anticoagulants Program Goals Anticoagulants in CAD PAD and AP Therapies Antithrombotic Strategies for PAD Antithrombotic Strategies for PAD (cont) Epidemiology, Pathophysiology, Diagnosis and Follow-up for Patients with Unknown Stroke Etiology. Stroke as a Health care Issue in the U.S.. ≈795,000,000 . new or recurrent strokes. . yearly. 87% . Assoc. iate. . . Prof Tatjana Šimurina MD, PhD. General Hospital Zadar; . Dept. .. . of Health Study, University of Zadar; . Assist Prof - Medical faculty, University of Osijek . tsimurina@unizd.hr. Assist.Lect. . . Shaymaa. . Hasan. Abbas. DESIRED TREATMENT OUTCOMES. The short-term goals of treatment for acute ischemic stroke include reducing secondary brain damage by re-establishing and maintaining adequate perfusion to marginally ischemic areas of the brain and to protect these areas from the effects of ischemia (i.e., . Prevalence of post-stroke fatigue. Post-stroke fatigue has been associated with:. 1. Depression and anxiety. Lower levels of physical activity. Possible inflammation. Post-stroke fatigue improves in approximately . ischaemic. attack in patients with. a diagnosis of resolved atrial fibrillation: . retrospective cohort. . studies.. Nicola J Adderley, . Krishnarajah. . Nirantharakumar. , Tom Marshall.. BMJ 2018.